Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe Quandt

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Annual Review of Medicine|September 4, 2020
Autoimmune Endocrinopathies: An Emerging Complication of Immune Checkpoint InhibitorsZoe Quandt, Arabella Young, Ana Luisa Perdigoto, et al.
Nature Biotechnology|January 2, 2023
Protection of cell therapeutics from antibody-mediated killing by CD64 overexpressionAlessia Gravina, Grigol Tediashvili, Raja Rajalingam, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 14, 2009
Association of age, stature, and education with ocular dimensions in an older white populationKristine E Lee, Barbara E K Klein, Ronald Klein, et al.
BMC Cancer|March 18, 2015
The association of alcohol consumption with mammographic density in a multiethnic urban populationZoe Quandt, Julie D Flom, Parisa Tehranifar, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2026
GLP- 1 Receptor Agonists in Patients with Cancer are Associated with Reduced All-Cause Mortality and HospitalizationAditya Mahadevan, Aidan Vosooghi, Jagmeet S Arora, et al.
The Oncologist|June 19, 2023
Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint InhibitorsJordyn Silverstein, Francis Wright, Michelle Wang, et al.
Current Diabetes Reports|December 13, 2021
Patient-Centered Diabetes Care of Cancer PatientsAnupam Kotwal, Yee-Ming M Cheung, Grace Cromwell, et al.
Frontiers in Endocrinology|November 29, 2023
Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitusRobin Hilder, Karen Tsai, Zoe Quandt, et al.
Frontiers in Endocrinology|April 16, 2026
Accuracy of glutamic acid decarboxylase antibodies for the identification of adult-onset type 1 diabetes mellitus: a systematic review and meta-analysisMandy M Shao, Agatha F Scheideman, Allen M Zhou, et al.
Med (New York, N.Y.)|April 18, 2026
Impact of baseline medications on real-world overall survival in immune checkpoint inhibitor-treated patients with cancer in the RADIOHEAD cohortSamantha Stone, Muhammad Zaki Fadlullah, Yuxin Zhao, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Annual Review of Medicine|September 4, 2020
Autoimmune Endocrinopathies: An Emerging Complication of Immune Checkpoint InhibitorsZoe Quandt, Arabella Young, Ana Luisa Perdigoto, et al.
Nature Biotechnology|January 2, 2023
Protection of cell therapeutics from antibody-mediated killing by CD64 overexpressionAlessia Gravina, Grigol Tediashvili, Raja Rajalingam, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 14, 2009
Association of age, stature, and education with ocular dimensions in an older white populationKristine E Lee, Barbara E K Klein, Ronald Klein, et al.
BMC Cancer|March 18, 2015
The association of alcohol consumption with mammographic density in a multiethnic urban populationZoe Quandt, Julie D Flom, Parisa Tehranifar, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2026
GLP- 1 Receptor Agonists in Patients with Cancer are Associated with Reduced All-Cause Mortality and HospitalizationAditya Mahadevan, Aidan Vosooghi, Jagmeet S Arora, et al.
The Oncologist|June 19, 2023
Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint InhibitorsJordyn Silverstein, Francis Wright, Michelle Wang, et al.
Current Diabetes Reports|December 13, 2021
Patient-Centered Diabetes Care of Cancer PatientsAnupam Kotwal, Yee-Ming M Cheung, Grace Cromwell, et al.
Frontiers in Endocrinology|November 29, 2023
Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitusRobin Hilder, Karen Tsai, Zoe Quandt, et al.
Frontiers in Endocrinology|April 16, 2026
Accuracy of glutamic acid decarboxylase antibodies for the identification of adult-onset type 1 diabetes mellitus: a systematic review and meta-analysisMandy M Shao, Agatha F Scheideman, Allen M Zhou, et al.
Med (New York, N.Y.)|April 18, 2026
Impact of baseline medications on real-world overall survival in immune checkpoint inhibitor-treated patients with cancer in the RADIOHEAD cohortSamantha Stone, Muhammad Zaki Fadlullah, Yuxin Zhao, et al.
Pageof 5